Phapros Tbk PT (PEHA) - Net Assets

Latest as of March 2026: Rp428.24 Billion IDR ≈ $25.09 Million USD

Based on the latest financial reports, Phapros Tbk PT (PEHA) has net assets worth Rp428.24 Billion IDR (≈ $25.09 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp1.43 Trillion ≈ $83.80 Million USD) and total liabilities (Rp1.00 Trillion ≈ $58.70 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Phapros Tbk PT tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rp428.24 Billion
% of Total Assets	29.94%
Annual Growth Rate	1.67%
5-Year Change	-42.31%
10-Year Change	-31.28%
Growth Volatility	17.86

Phapros Tbk PT - Net Assets Trend (2011–2025)

This chart illustrates how Phapros Tbk PT's net assets have evolved over time, based on quarterly financial data. See Phapros Tbk PT (PEHA) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Phapros Tbk PT (2011–2025)

The table below shows the annual net assets of Phapros Tbk PT from 2011 to 2025. For live valuation and market cap data, see Phapros Tbk PT stock valuation.

Year	Net Assets	Change
2025-12-31	Rp427.47 Billion ≈ $25.05 Million	+8.74%
2024-12-31	Rp393.12 Billion ≈ $23.04 Million	-48.97%
2023-12-31	Rp770.33 Billion ≈ $45.14 Million	-0.19%
2022-12-31	Rp771.82 Billion ≈ $45.23 Million	+4.16%
2021-12-31	Rp740.98 Billion ≈ $43.42 Million	+0.01%
2020-12-31	Rp740.91 Billion ≈ $43.41 Million	-9.82%
2019-12-31	Rp821.61 Billion ≈ $48.14 Million	+4.03%
2018-12-31	Rp789.80 Billion ≈ $46.28 Million	+12.60%
2017-12-31	Rp701.39 Billion ≈ $41.10 Million	+12.75%
2016-12-31	Rp622.08 Billion ≈ $36.45 Million	+38.33%
2015-12-31	Rp449.72 Billion ≈ $26.35 Million	+10.16%
2014-12-31	Rp408.25 Billion ≈ $23.92 Million	+4.31%
2013-12-31	Rp391.40 Billion ≈ $22.93 Million	+4.20%
2012-12-31	Rp375.63 Billion ≈ $22.01 Million	+10.75%
2011-12-31	Rp339.17 Billion ≈ $19.87 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Phapros Tbk PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 641.5% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Rp84.00 Billion	20.26%
Other Comprehensive Income	Rp663.72 Billion	160.12%
Other Components	Rp17.14 Billion	4.13%
Total Equity	Rp414.52 Billion	100.00%

Phapros Tbk PT Competitors by Market Cap

The table below lists competitors of Phapros Tbk PT ranked by their market capitalization.

Company	Market Cap
FirstGroup PLC LSE:FGP	$12.51 Million
Bayhorse Silver Inc V:BHS	$12.51 Million
Smith Micro Software Inc NASDAQ:SMSI	$12.51 Million
SSR Inc KQ:275630	$12.51 Million
Park & Bellheimer AG F:PKB	$12.50 Million
Grand Pacific Petrochemical Corp Pref TW:1312A	$12.49 Million
Bflysoft Co. Ltd. KQ:148780	$12.49 Million
Next Biometrics Group ASA OL:NEXT	$12.49 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Phapros Tbk PT's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 379,753,679,000 to 414,519,489,000, a change of 34,765,810,000 (9.2%).
Net income of 28,031,391,000 contributed positively to equity growth.
Dividend payments of 8,565,000 reduced retained earnings.
Other comprehensive income increased equity by 8,318,791,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rp28.03 Billion	+6.76%
Dividends Paid	Rp8.56 Million	-0.0%
Other Comprehensive Income	Rp8.32 Billion	+2.01%
Other Changes	Rp-1.58 Billion	-0.38%
Total Change	Rp-	9.15%

Book Value vs Market Value Analysis

This analysis compares Phapros Tbk PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.51x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 0.63x to 0.51x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2011-12-31	Rp403.77	Rp254.00	x
2012-12-31	Rp437.19	Rp254.00	x
2013-12-31	Rp455.92	Rp254.00	x
2014-12-31	Rp486.01	Rp254.00	x
2015-12-31	Rp535.38	Rp254.00	x
2016-12-31	Rp740.57	Rp254.00	x
2017-12-31	Rp834.99	Rp254.00	x
2018-12-31	Rp916.58	Rp254.00	x
2019-12-31	Rp952.99	Rp254.00	x
2020-12-31	Rp856.73	Rp254.00	x
2021-12-31	Rp856.53	Rp254.00	x
2022-12-31	Rp894.11	Rp254.00	x
2023-12-31	Rp892.30	Rp254.00	x
2024-12-31	Rp452.09	Rp254.00	x
2025-12-31	Rp493.48	Rp254.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Phapros Tbk PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.76%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.98%
• Asset Turnover: 0.68x
• Equity Multiplier: 3.35x
Recent ROE (6.76%) is above the historical average (5.35%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	19.07%	13.75%	1.02x	1.36x	Rp30.78 Billion
2012	18.83%	13.06%	0.95x	1.52x	Rp32.44 Billion
2013	10.99%	8.07%	0.81x	1.68x	Rp3.81 Billion
2014	11.10%	7.84%	0.91x	1.56x	Rp4.50 Billion
2015	14.01%	9.12%	1.02x	1.51x	Rp18.04 Billion
2016	13.99%	10.66%	0.92x	1.42x	Rp24.79 Billion
2017	17.86%	12.50%	0.85x	1.68x	Rp55.13 Billion
2018	17.18%	12.93%	0.55x	2.43x	Rp55.31 Billion
2019	12.75%	9.23%	0.53x	2.62x	Rp21.98 Billion
2020	6.74%	4.94%	0.51x	2.66x	Rp-23.48 Billion
2021	1.54%	1.05%	0.57x	2.56x	Rp-60.88 Billion
2022	3.74%	2.40%	0.65x	2.41x	Rp-47.04 Billion
2023	0.80%	0.59%	0.57x	2.36x	Rp-68.99 Billion
2024	-75.07%	-38.28%	0.52x	3.77x	Rp-323.04 Billion
2025	6.76%	2.98%	0.68x	3.35x	Rp-13.42 Billion

Industry Comparison

This section compares Phapros Tbk PT's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $883,075,311,215
Average return on equity (ROE) among peers: 12.00%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Phapros Tbk PT (PEHA)	Rp428.24 Billion	19.07%	2.34x	$12.50 Million
Darya-Varia Laboratoria Tbk (DVLA)	$962.43 Billion	8.41%	0.28x	$104.02 Million
Indofarma Tbk (INAF)	$430.33 Billion	0.01%	2.98x	$22.88 Million
Merck Tbk (MERK)	$512.22 Billion	34.25%	0.36x	$95.29 Million
Pyridam Farma Tbk (PYFA)	$66.94 Billion	2.60%	0.42x	$134.32 Million
Tempo Scan Pacific Tbk (TSPC)	$2.44 Trillion	14.73%	0.34x	$663.29 Million

About Phapros Tbk PT

JK:PEHA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$12.50 Million

Rp213.36 Billion IDR

Market Cap Rank

#26485 Global

#582 in Indonesia

Share Price

Rp254.00

Change (1 day)

-2.31%

52-Week Range

Rp214.00 - Rp384.00

All Time High

Rp2996.89